Financhill
Back

MustGrow Biologics Quote, Financials, Valuation and Earnings

Sell
10

MGROF
MustGrow Biologics

Last Price:
0.74
Seasonality Move:
13.06%

7 Day Trial

ALL ACCESS PASS

$ 7

MustGrow Biologics Price Quote

$0.74
0.00 (-2.06%)
(Updated: May 18, 2024 at 5:48 AM ET)

MustGrow Biologics Key Stats

Sell
10
MustGrow Biologics (MGROF) is a Sell

Day range:
$0.74 - $0.81
52-week range:
$0.57 - $1.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
9.12%

Volume:
690
Avg. volume:
14.7K
1-year change:
-52.89%
Market cap:
$38.4M
Revenue:
$3.5M
EPS:
$-0.01

How Much Does MustGrow Biologics Make?

Data Unavailable

Is MustGrow Biologics Growing As A Company?

  • What Is MustGrow Biologics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3453.54%
  • What Is MustGrow Biologics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

MustGrow Biologics Stock Price Performance

What Is MustGrow Biologics 52-Week High & Low?

MustGrow Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MustGrow Biologics?

  • How Much Debt Does MustGrow Biologics Have?
    Total long term debt quarterly is $572.4K
  • How Much Cash Does MustGrow Biologics Have?
    Cash and short term investments quarterly total is $5.1M
  • What Is MustGrow Biologics’s Book Value Per Share?
    Book value per share is 0.08

Is MustGrow Biologics Cash Flow Positive?

Data Unavailable

MustGrow Biologics Return On Invested Capital

  • Is Management Doing A Good Job?
    MGROF return on invested capital is -9.29%
  • What Is MustGrow Biologics Return On Assets?
    ROA measures how assets are converting to revenues and is -7.76%
  • What Is MGROF Return On Equity?
    ROE is a measure of profitability and is -10.78%

MustGrow Biologics Earnings Date & Stock Price

MustGrow Biologics Competitors

  • Who Are MustGrow Biologics's Competitors?
    Below is a list of companies who compete with MustGrow Biologics or are related in some way:
    • Austin Gold Corp (AUST)
    • Flexible Solutions International Inc (FSI)
    • Gold Royalty Corp (GROY)
    • Paramount Gold Nevada Corp (PZG)
    • Solitario Resources Corp (XPL)

MustGrow Biologics Dividend Yield

Data Unavailable

MustGrow Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 345353.89% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable